Babao Dan ((sic)) Alleviates 5-Fluorouracil-Induced Intestinal Damage via Wnt/β-Catenin Pathway

被引:6
|
作者
Gui, Meng-xuan [1 ]
Huang, Bin [1 ]
Peng, Jun [1 ]
Chen, Xi [2 ]
Muthu, Ragunath [1 ]
Gao, Ying [1 ]
Wang, Rui-guo [1 ]
Lin, Jiu-mao [1 ]
机构
[1] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fujian Key Lab Integrat Med Geriatr, Fuzhou 350122, Peoples R China
[2] 900 Hosp Joint Logist Team Support Force, Dept Med Oncol, Fuzhou 350025, Peoples R China
关键词
5-flurouracil; Babao Dan; body weight; diarrhea; intestinal mucositis; Wnt/beta-catenin pathway; STEM-CELLS; CANCER; MUCOSITIS; RATS;
D O I
10.1007/s11655-021-3282-0
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective To evaluate the protective function of Babao Dan ((sic), BBD) on 5-flurouracil (5-FU)-induced intestinal mucositis (IM) and uncover the underlying mechanism. Methods A total of 18 male mice were randomly divided into 3 groups by a random number table, including control, 5-FU and 5-FU combined BBD groups, 6 mice in each group. A single intraperitoneal injection of 5-FU (150 mg/kg) was performed in 5-FU and 5-FU combined BBD groups on day 0. Mice in 5-FU combined BBD group were gavaged with BBD (250 mg/kg) daily from day 1 to 6. Mice in the control group were gavaged with saline solution for 6 days. The body weight and diarrhea index of mice were recorded daily. On the 7th day, the blood from the heart of mice was collected to analyze the proportional changes of immunological cells, and the mice were subsequently euthanized by mild anesthesia with 2% pentobarbital sodium. Colorectal lengths and villus heights were measured. Intestinal-cellular apoptosis and proliferation were evaluated by Tunel assay and immunohistochemical staining of proliferating cell nuclear antigen, respectively. Immunohistochemistry and Western blot were performed to investigate the expressions of components in Wnt/beta-catenin pathway (Wnt3, LRP5, beta-catenin, c-Myc, LRG5 and CD44). Results BBD obviously alleviated 5-FU-induced body weight loss and diarrhea, and reversed the decrease in the number of white blood cells, including monocyte, granulocyte and lymphocyte, and platelet (P<0.01). The shortening of colon caused by 5-FU was also reversed by BBD (P<0.01). Moreover, BBD inhibited apoptosis and promoted proliferation in jejunum tissues so as to reduce the intestinal mucosal damage and improve the integrity of villus and crypts. Mechanically, the expression levels of Wnt/beta-catenin mediators such as Wnt3, LRP5, beta-catenin were upregulated by BBD, activating the transcription of c-Myc, LRG5 and CD44 (P<0.01). Conclusions BBD attenuates the adverse effects induced by 5-FU via Wnt/beta-catenin pathway, suggesting it may act as a potential agent against chemotherapy-induced intestinal mucositis.
引用
收藏
页码:1000 / 1006
页数:7
相关论文
共 50 条
  • [31] Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis
    Li, Bing-rong
    Shao, Shi-yun
    Yuan, Long
    Jia, Ru
    Sun, Jian
    Ji, Qing
    Sui, Hua
    Zhou, Li-hong
    Zhang, Yi
    Liu, Hui
    Li, Qi
    Wang, Yan
    Zhang, Bi-meng
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (02): : 144 - 157
  • [32] Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents
    Atiq, Ayesha
    Shal, Bushra
    Naveed, Muhammad
    Khan, Adnan
    Ali, Jawad
    Zeeshan, Sara
    Al-Shararic, Shakir D.
    Kim, Yeong Shik
    Khan, Salman
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 843 : 292 - 306
  • [33] Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution
    Pedro M. G. Soares
    José Maurício S. C. Mota
    Antoniella S. Gomes
    Ricardo B. Oliveira
    Ana Maria S. Assreuy
    Gerly Anne C. Brito
    Armênio A. Santos
    Ronaldo A. Ribeiro
    Marcellus H. L. P. Souza
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 91 - 98
  • [34] Bletilla oligosaccharides improved 5-fluorouracil-induced intestinal mucositis in mice by activating NF-κB signalling pathway and regulating intestinal microbiota
    Yin, Qiuxiong
    Li, Xinran
    Xiong, Yanli
    Jiang, Yupeng
    Ma, Shengsuo
    Qian, Guoqiang
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [35] Modified Pulsatilla decoction alleviates 5-fluorouracil-induced intestinal mucositis by modulating the TLR4/MyD88/NF-κB pathway and gut microbiota
    Qiu, Yi-Tong
    Luo, Xin-Yi
    Deng, Ya-Feng
    Zheng, Xue
    Qiu, Jian-Guo
    Zhang, Lin-Sheng
    Huang, Xiao-Qi
    Zheng, Xue-Bao
    Huang, Hai-Yang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (07)
  • [36] Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model
    Ali, Jawad
    Khan, Ashraf Ullah
    Shah, Fawad Ali
    Ali, Hussain
    Ul Islam, Salman
    Kim, Yeong Shik
    Khan, Salman
    LIFE SCIENCES, 2019, 239
  • [37] Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats
    Prisciandaro, Luca D.
    Geier, Mark S.
    Butler, Ross N.
    Cummins, Adrian G.
    Howarth, Gordon S.
    CANCER BIOLOGY & THERAPY, 2011, 11 (07) : 671 - 677
  • [38] Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
    Ribeiro, Ronaldo A.
    Wanderley, Carlos W. S.
    Wong, Deysi V. T.
    Mota, Jose Mauricio S. C.
    Leite, Caio A. V. G.
    Souza, Marcellus H. L. P.
    Cunha, Fernando Q.
    Lima-Junior, Roberto C. P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (05) : 881 - 893
  • [39] Dose-dependent Effect of Oxytocin on 5-Fluorouracil-induced Intestinal Mucositis in Rats
    Chukwunyere, Ugochukwu
    Sehirli, Ahmet Ozer
    Sayiner, Serkan
    Ceylanli, Deniz
    Mercan, Merve
    Cetinel, Sule
    Calis, Ihsan
    Abacioglu, Nurettin
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (12): : 2476 - 2484
  • [40] Volatile Oil from Amomi Fructus Attenuates 5-Fluorouracil-Induced Intestinal Mucositisd
    Zhang, Ting
    Lu, Shan H.
    Bi, Qian
    Liang, Li
    Wang, Yan F.
    Yang, Xing X.
    Gu, Wen
    Yu, Jie
    FRONTIERS IN PHARMACOLOGY, 2017, 8